Dalal P, Shousha S
Department of Histopathology, Charing Cross and Westminster Medical School, London, England.
Mod Pathol. 1995 May;8(4):413-6.
This investigation was aimed at studying the distribution of keratin 19 in various histological types of invasive breast carcinoma and benign breast lesions using two different antibodies, comparing the results, and assessing the significance of the finding. In particular, the usefulness of using the absence of keratin 19 immunostaining as a marker for medullary carcinoma was examined. Paraffin sections of 49 invasive breast carcinomas and 40 benign lesions were examined by the avidin-biotin complex immunoperoxidase technique using two commercially available keratin 19-specific monoclonal antibodies, BA17 and RCK 108. The results showed that the latter antibody stained more cases and the intensity of its staining was more pronounced than BA17. Most medullary and poorly differentiated invasive ductal carcinomas were BA17 negative and RCK108 negative or weakly positive. Moderately and well-differentiated ductal, invasive lobular, tubular, and most mucinous carcinomas were mostly positive with both antibodies, whereas a case of signet ring and a case of spindle cell carcinoma were negative with the two antibodies. Thirty eight of the 40 benign lesions examined showed variable numbers of positive cells, reflecting in general the pattern seen in normal ducts and acini. It is concluded that although keratin 19 seems to be completely absent or at most only weakly represented in paraffin sections of medullary carcinoma, similar reactions are obtained with poorly differentiated ductal tumors. Different antibodies may give different reactions, but well-differentiated ductal and invasive lobular tumors are usually more strongly stained, whereas signet ring and spindle cell carcinomas seem to be negative.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在使用两种不同抗体研究细胞角蛋白19在各种组织学类型的浸润性乳腺癌和乳腺良性病变中的分布,比较结果并评估该发现的意义。特别地,研究了将细胞角蛋白19免疫染色缺失用作髓样癌标志物的实用性。采用抗生物素蛋白-生物素复合物免疫过氧化物酶技术,使用两种市售的细胞角蛋白19特异性单克隆抗体BA17和RCK 108,对49例浸润性乳腺癌和40例良性病变的石蜡切片进行检查。结果显示,后一种抗体染色的病例更多,且其染色强度比BA17更明显。大多数髓样癌和低分化浸润性导管癌BA17阴性且RCK108阴性或弱阳性。中分化和高分化导管癌、浸润性小叶癌、管状癌以及大多数黏液癌两种抗体大多呈阳性,而1例印戒细胞癌和1例梭形细胞癌两种抗体均为阴性。所检查的40例良性病变中有38例显示不同数量的阳性细胞,总体反映了正常导管和腺泡中的模式。结论是,虽然在髓样癌石蜡切片中细胞角蛋白19似乎完全缺失或最多仅微弱表达,但低分化导管肿瘤也有类似反应。不同抗体可能产生不同反应,但高分化导管癌和浸润性小叶癌通常染色更强,而印戒细胞癌和梭形细胞癌似乎为阴性。(摘要截短于250字)